ACT

JANUARY 29/2019


Advertisement

news roundup

Merger Announced for Factory-CRO and Boston Biomedical Associates

Factory-CRO Group, a global CRO and Boston Biomedical Associates (BBA), a full-service Medical Device/Biotechnology CRO and Consultancy announced that they have merged the organizations.

Advertisement

Tell us what you think about clinical operations and receive a $5 Amazon gift card!
Take the short survey


Global Sample Processing Network Announced by LabConnect

LabConnect, a global provider of central laboratory and support services, is pleased to announce a new service: LabConnect's global sample processing network (GSPN). This GSPN will offer a global solution for sample preparation and processing requirements.


Advertisement

Introducing Cross-Trial LMS: A Simple, Efficient, and Intuitive Way to Send Bulk Training
On Demand
Read More


PHARMASEAL Launches Engility CTMS

PHARMASEAL, a new provider of clinical trial management and governance solutions, has launched Engility CTMS, the first product to be released from its Engility B2B platform. This new CTMS has been designed in hopes to increase the level of governance and control that organizations demand from their management systems to enable effective oversight of their clinical trials.


IDDI starts Research on Statistical Method for individualization of Therapy

Clinical services provider International Drug Development Institute (IDDI) is forming a research collaborative into the use of a new statistical method called Generalized Pairwise Comparisons (GPC). The objective of the collaborative is to establish proof of the concept that the GPC method can complement traditional methods for the design, analysis and interpretation of clinical trial results in regard to accounting for multiple endpoints at once and ranked in order of priority. In addition to IDDI's lead, the collaborative includes Bristol-Myers Squibb, the European Organization for Research and Treatment of Cancer (EORTC), the Université Catholique de Louvain and the University Hospital and Cancer Center of Lyon.


advertisement

In this edition

PHARMASEAL Launches Engility CTMS
The Turning Point for Clinical Research: Global Data Standardization
Brexit or no Brexit, it's an EMA Exit

Subscribe

Subscribe

Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »

Events

Clinical Data Disclosure and Transparency (Today & Tomorrow)
Patient Registries and Real-World Evidence Summit
DIA Europe 2019
Search Upcoming Events

Articles

The Turning Point for Clinical Research: Global Data Standardization

Clinical research is only as effective as its ability to have an impact on health.


Breaking Down OHRP Assurances

This article focuses on specific requirements to ensure the Protection of Human Research Subjects.


Blog Posts

Tools for Resolving Monitoring Visit Findings

In this article, Moe Alsumidaie will discuss how study teams manage monitoring reports and offer a tracking tool to assist sites with the process.


Brexit or no Brexit, it's an EMA Exit

The British government and the country's squabbling parliament are still incapable of deciding when—or even if—the UK should leave the European Union, still less how.


Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription

Get the full picture


Ask the editor

Lisa Henderson
Editor in Chief
Lisa.Henderson@ubm.com

Advertise

Todd Baker
Group Publisher
todd.baker@ubm.com